STOCK TITAN

DataMeds AI: Hyperscale reports 9.99% ownership

The reported position assumes note conversion at the initial floor price of $1.00 per share and excludes additional note and warrant shares subject to ownership blockers.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

DataMeds AI, Inc. common stock is the subject of Hyperscale Data, Inc.’s report of beneficial ownership of 501,204 shares, or 9.99% of the class. Hyperscale reported shared voting and dispositive power over the shares, which are issuable upon conversion of a convertible promissory note held by Ault Lending, LLC. The reported calculation assumes conversion at the initial floor price of $1.00 per share. It excludes 123,796 additional shares issuable under the note due to a 9.99% beneficial ownership blocker and 245,419 shares issuable upon warrant exercise due to a 4.99% blocker. DataMeds AI had 4,515,862 shares issued and outstanding as of August 18, 2026.

Beneficially owned 501,204 shares Common stock issuable upon conversion of a note
Percent of class 9.99% Reported beneficial ownership
Shares issued and outstanding 4,515,862 shares As of August 18, 2026
Initial floor price $1.00 per share Assumed conversion price for the note
Additional note shares excluded 123,796 shares Excluded due to a 9.99% beneficial ownership blocker
Warrant shares excluded 245,419 shares Excluded due to a 4.99% beneficial ownership blocker
Warrant beneficial ownership blocker 4.99% Applies to shares issuable upon warrant exercise
convertible promissory note financial
"issuable upon conversion of a convertible promissory note held by Ault Lending, LLC"
A convertible promissory note is a loan a company takes now that can later be turned into shares instead of being repaid in cash. Think of it as lending money with the option to accept ownership in the business down the road; that matters to investors because it affects who gets paid first, how much ownership existing shareholders keep, and the company’s future valuation and cash needs. Terms such as conversion price, interest and maturity determine the financial impact.
beneficial ownership blocker financial
"due to a 9.99% beneficial ownership blocker"
A beneficial ownership blocker is a legal or structural device that prevents a shareholder from being treated as the ultimate owner of enough shares to trigger control, reporting, or voting thresholds. Think of it like a speed bump that stops an investor from reaching a stake size that would force corporate disclosure or change control rights. Investors care because it affects who controls the company, how shares vote, regulatory filings, takeover risk and therefore potential value or liquidity of their holdings.
initial floor price financial
"conversion price equal to the initial floor price of $1.00 per share"
shared dispositive power financial
"Shared Dispositive Power 501,204.00"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MEDS shares did Hyperscale Data report beneficially owning?

Hyperscale Data reported beneficial ownership of 501,204 shares of DataMeds AI common stock, or 9.99% of the class. The shares are issuable upon conversion of a convertible promissory note held by Ault Lending, LLC.

What additional MEDS shares were excluded from the reported ownership?

The report excludes 123,796 additional shares issuable upon conversion of the note due to a 9.99% beneficial ownership blocker and 245,419 shares issuable upon exercise of Ault Lending, LLC’s warrants due to a 4.99% beneficial ownership blocker. The note-share figures assume conversion at the initial floor price of $1.00 per share.

What share count was used to calculate Hyperscale Data’s MEDS ownership percentage?

DataMeds AI had 4,515,862 shares issued and outstanding as of August 18, 2026. Hyperscale’s reported ownership percentage was based on that share count.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





949503205

(CUSIP Number)
05/27/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) Represents 501,204 shares of Common Stock issuable upon conversion of a convertible promissory note held by Ault Lending, LLC (the "Convertible Note"). Does not include (i) an additional 123,796 shares of Common Stock issuable upon conversion of the Convertible Note due to a 9.99% beneficial ownership blocker or (ii) 245,419 shares of Common Stock issuable upon exercise of warrants held by Ault Lending, LLC due to a 4.99% beneficial ownership blocker. Such figures assume, for purposes of this Schedule 13G, the conversion of the note at a conversion price equal to the initial floor price of $1.00 per share. (2) Based on 4,515,862 shares issued and outstanding as of August 18, 2026, as disclosed by the Issuer in the Definitive Information Statement filed with the SEC on November 9, 2026.


SCHEDULE 13G



Hyperscale Data, Inc.
Signature:/s/ Milton C. Ault, III
Name/Title:Executive Chairman
Date:11/10/2026
Exhibit Information

99.1 - Identification of the Subsidiary that Acquired the Security Being Reported on by the Parent Holding Company

Keep reading